Vissing, J, Jacob, S, Fujita, K P, O’Brien, F, Howard, J F, The REGAIN Study Group, Mazia, C G, Wilken, M, Barroso, F, Saba, J, Rugiero, M, Bettini, M, Chaves, M, Vidal, G, Garcia, A D, De Bleecker, J, Van den Abeele, G, de Koning, K, De Mey, K, Mercelis, R, Mahieu, D, Wagemaekers, L, Van Damme, P, Depreitere, A, Schotte, C, Smetcoren, C, Stevens, O, Van Daele, S, Vandenbussche, N, Vanhee, A, Verjans, S, Vynckier, J, D’Hont, A, Tilkin, P, Alves de Siqueira Carvalho, A, Dias Brockhausen, I, Feder, D, Ambrosio, D, César, P, Melo, A P, Martins Ribeiro, R, Rocha, R, Rosa, B B, Veiga, T, da Silva, L A, Andersen, H, Harbo, T, Vinge, L, Krogh, S, Mogensen, A, Vissing, J, Højgaard, J, Witting, N, Autzen, A M O, Pedersen, J & Weiss, M 2020, ' ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab ', Journal of Neurology, vol. 267, pp. 1991-2001 . https://doi.org/10.1007/s00415-020-09770-y JOURNAL OF NEUROLOGY Journal of Neurology Journal of neurology, 267(7), 1991-2001. D. Steinkopff-Verlag
Neurology, 93(1), E59-E76. Lippincott Williams and Wilkins Neurology, 93(1), E59-E76. Lippincott Williams & Wilkins Neurology, 93(1), E59-E76. LIPPINCOTT WILLIAMS & WILKINS Verboon, C, Doets, A Y, Galassi, G, Davidson, A, Waheed, W, Pereon, Y, Shahrizaila, N, Kusunoki, S, Lehmann, H C, Harbo, T, Monges, S, Van den Bergh, P, Willison, H J, Cornblath, D R, Jacobs, B C & IGOS Consortium 2019, ' Current treatment practice of Guillain-Barre syndrome ', Neurology, vol. 93, no. 1, pp. E59-E76 . https://doi.org/10.1212/WNL.0000000000007719 Neurology, Vol. 93, no. 1, p. e59-e76 (2019)
Andersen, H, Mantegazza, R, Wang, J J, O’Brien, F, Patra, K, Howard, J F & The REGAIN Study Group 2019, ' Eculizumab improves fatigue in refractory generalized myasthenia gravis ', Quality of Life Research, vol. 28, no. 8, pp. 2247-2254 . https://doi.org/10.1007/s11136-019-02148-2 Quality of Life Research QUALITY OF LIFE RESEARCH